Datexim

Datexim created a new solution to decrease the number of missed cases while drastically reducing the time needed to screen a slide. The first AI-based image analysis solution for cervical cancer screening is on the market thanks to the CE certification of CytoProcessor, and we go on with passion to improve our solutions. We also have the ambition to give access to diagnosis and prevention to low-resource countries thanks to a dedicated platform.

53.6
53.6
NaN
NaN
NaN
NaN
Links
Valuation
$
Funding
$ 1.78 M
$ 1.78 M
Statistics
NA

Datexim created a new solution to decrease the number of missed cases while drastically reducing the time needed to screen a slide. The first AI-based image analysis solution for cervical cancer screening is on the market thanks to the CE certification of CytoProcessor, and we go on with passion to improve our solutions. We also have the ambition to give access to diagnosis and prevention to low-resource countries thanks to a dedicated platform.

Overview
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
0and0